Lijun Dou

Lijun Dou

Auto-generated profile, based on publicly available information

Lijun Dou

Cleveland Clinic, Cleveland, OH USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Frontiers in Microbiology
Verified
Journal Article
Open access
MWMeiling Wang
Meiling Wang
ZSZhaoqi Song
Zhaoqi Song
SLShirong Lai
Shirong Lai
FTFurong Tang
Furong Tang
LDLijun Dou
Lijun Dou
FYFenglong Yang
Fenglong Yang
Depression is one of the most prevalent mental disorders today. Over the past decade, there has been considerable attention given to the field of gut microbiota associated with depression. A substantial body of research indicates a bidirectional communication pathway between gut microbiota and the brain. In this review, we extensively detail the correlation between gut microbiota, including Lactobacillus acidophilus and Bifidobacterium longum, and metabolites such as short-chain fatty acids (SCFAs) and 5-hydroxytryptamine (5-HT) concerning depression. Furthermore, we delve into the potential health benefits of microbiome-targeted therapies, encompassing probiotics, prebiotics, and synbiotics, in alleviating depression. Lastly, we underscore the importance of employing a constraint-based modeling framework in the era of systems medicine to contextualize metabolomic measurements and integrate multi-omics data. This approach can offer valuable insights into the complex metabolic host-microbiota interactions, enabling personalized recommendations for potential biomarkers, novel drugs, and treatments for depression.

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LDLijun Dou
Lijun Dou
JXJielin Xu
Jielin Xu
YHYuan Hou
Yuan Hou
FCFeixiong Cheng
Feixiong Cheng
Background: Cell‐type specific expression quantitative trait loci (eQTLs) can help dissect cellular heterogeneity in the impact of genetic variation on gene expression for Alzheimer’s disease (AD) and AD‐related dementia (ADRD). However, due to the high cost and stringent sample collection criteria, it is challenging to obtain large single‐nuclei RNA sequencing (snRNA‐seq) data with sufficient cohort size to match genotyping data to systematically identify human brain‐specific eQTLs for AD/ADRD.Method: In this study, we presented a deep learning‐based deconvolution framework on large‐scale bulk RNA sequencing (RNA‐seq) data to infer cell‐type specific eQTLs in the human brains with AD/ADRD. Specifically, we first predicted the brain cell‐type specific gene expression for the harmonized bulk RNA dataset (n = 1,092) from Religious Orders Study and Memory and Aging Project (ROS/MAP). We then incorporated the inferred cell‐type specific gene expression with matched whole genome sequencing (WGS) data from ROS/MAP to identify the brain cell‐type specific eQTLs. These cell‐type specific eQTLs were further colocalized with AD genome‐wide association study (GWAS) findings to discover potential risk genes and druggable targets for AD.Result: We identified 44,504 genome‐wide significant cell‐type specific cis‐eQTLs (window size = 1Mb, p < 5 × 10‐8) from eight brain cell types, including excitatory neurons, inhibitory neurons, microglia, oligodendrocytes, oligodendrocyte precursor cells, astrocytes, and endothelium. Approximate 2,732 eQTLs in astrocytes and 7,628 in excitatory neurons are identical to the results from a large existing snRNA‐seq data, associated with the regulation of multiple genes (eGenes, e.g., ARL17B, LRRC37A2, ERAP2, PILRB, ZNF266). We illustrated that the GWAS variant rs199456 (AD GWAS: p = 2.57 × 10‐9) co‐localized with its regulatory effect on LRRC37A2, LRRC37A and ARL17B gene expression in excitatory neurons.Conclusion: In summary, this study presented comprehensive brain cell type‐specific eQTL analysis and identified potential eQTL‐regulated likely causal genes from AD GWAS findings using a deep learning‐based deconvolution framework. It offers an opportunity to efficiently discover the effect of GWAS loci on gene expression at cell type‐specific manners using genotyping data and matched bulk RNA‐seq data instead of costly snRNA‐seq data. Functional validation of candidate eQTLs and associated genes are warranted in the future.